SCHEMBL18015441

SCHEMBL18015441

Clc1ccccc1-c1nc(-c2ccccc2Cl)nc(-c2ccccc2Cl)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.54
HSP90AA1 P07900 1/20 0.53
CYP2A6 P11509 1/20 0.52
CYP1A2 P05177 2/20 0.52
CYP3A4 P08684 2/20 0.52
CYP2D6 P10635 2/20 0.52
CYP2C9 P11712 2/20 0.52
CYP2C19 P33261 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
MAPK1 P28482 1/20 0.52
HSD17B10 Q99714 1/20 0.52
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
TP53 P04637 2/20 0.50
HPGD P15428 2/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
LMNA P02545 2/20 0.47
TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29369217 0.93 HSP90AA1 (0.49) LDHAHSP90AA1CYP2A6CYP1A2CYP3A4
SCHEMBL18181000 0.89 CYP2A6 (0.60) LDHAHSP90AA1CYP2A6CYP1A2CYP3A4
SCHEMBL11400639 0.87 HSP90AA1 (0.49) LDHAHSP90AA1CYP2A6CYP1A2CYP3A4
SCHEMBL21563733 0.87 CYP2A6 (0.58) LDHAHSP90AA1CYP2A6CYP1A2CYP3A4
SCHEMBL3157424 0.85 HSP90AA1 (0.53) LDHAHSP90AA1CYP2A6CYP1A2CYP3A4
SCHEMBL23027107 0.85 CYP2A6 (0.56) HSP90AA1CYP2A6CYP1A2CYP3A4CYP2D6
SCHEMBL31624220 0.85 CYP2A6 (0.56) HSP90AA1CYP2A6CYP1A2CYP3A4CYP2D6
SCHEMBL2490905 0.84 HSP90AA1 (0.69) LDHAHSP90AA1CYP1A2CYP3A4CYP2D6
SCHEMBL29808150 0.84 HSP90AA1 (0.69) LDHAHSP90AA1CYP1A2CYP3A4CYP2D6
Clofentezine SCHEMBL30917908 0.83 LDHA (0.59) LDHAHSP90AA1CYP2A6CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11024815-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-01 US disclosed
EP-3254317-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-07-31 EP disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
WO-2016124304-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-08-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11024815-B2 Metal complexes EXOC4, EXOC3, TIMCC LDHA 2726/4885HSP90AA1 4412/4885CYP2A6 3821/4885
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 LDHA 1917/4885HSP90AA1 4143/4885CYP2A6 4002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.